duke clinical research institute zoominfo

Duke Clinical Research Institute

The largest academic research organization in the world, the DCRI is known for its pioneering research in cardiology but performs clinical research across the spectrum of diseases, ranging from:

• Phase I to phase IV clinical trials
• Outcomes and quality research
• Registries of more than 100,000 patients
• Economic and quality-of-life studies in populations spanning more than 20 therapeutic areas

The DCRI grew out of the Duke Databank for Cardiovascular Diseases, which is one of the world's largest repositories of follow-up on patients who have documented coronary heart disease (more than 200,000 patients have been enrolled to date). The DCRI has evolved into an organization with major efforts in clinical trials, outcomes research, and health policy, and the DCRI expanded beyond the cardiovascular therapeutic area beginning in 1996.

The DCRI faculty includes clinician researchers, biostatisticians, health economists, and health services researchers. Currently, the DCRI comprises approximately 1,300 employees, including more than 200 faculty from all disciplines. Most DCRI researchers are also active practicing physicians, studying the application of research to patient care.

Research Accomplishments

• Conducted studies at more than 3,500 sites in 64 countries
• More than 1,050,000 patients enrolled in DCRI studies
• More than 8,000 publications in peer-reviewed journals
• More than 730 phase I-IV trials and outcomes research projects completed
• More than 5,000 investigators worldwide 

Training Program

The DCRI offers a living laboratory for investigators of the future by combining faculty interests in specific research questions with the multifaceted environment needed to do outcome-based studies.

Trainees at the DCRI have the opportunity to experience firsthand the features of conducting domestic and international clinical trials and outcomes studies, including activities such as:

• Protocol development
• Study operations
• Continuing medical education curricula development
• Clinical events adjudication
• Operational functions such as project and data management, site management, and use of information technology specific to multi-center clinical research studies

Each cardiovascular trainee at the DCRI develops a relationship with a primary mentor who bears the responsibility of guiding the trainee’s career development. Within cardiovascular medicine, trainees are recommended to focus on either cardiovascular outcomes or clinical trials. However, trainees who focus on outcomes generally also work with at least one clinical trial, and clinical trial trainees generally conduct at least one database project. The mentor is expected to assist the fellow in developing a broad range of experiences with different types of faculty, not just to have the fellow work in his or her own research projects.

DCRI fellows attend a weekly DCRI Clinical Research Conference in which fellows, faculty, and visiting researchers present work in progress. The fellows also invite external leaders in cardiovascular medicine to conduct two-day visiting professor sessions including intensive small seminars with the fellows.

A critical component of the training program is the intense interaction between the clinician researchers and statisticians. The philosophy of the training program is that the most successful investigators in cardiovascular medicine will be able to combine superior knowledge of clinical cardiology with quantitative principles in an interactive, teamwork-oriented environment.

Cardiovascular fellows also have the opportunity to participate in coursework for the Clinical Research Training Program to obtain a Masters in Health Sciences in Clinical Research during their research fellowship at DCRI. This program offers in-depth training regarding biostatistics, clinical research design and methodology, cost-effectiveness research, and health economics.

The clinical research training offered to cardiovascular fellows at DCRI is unparalleled and represents a distinct advantage for trainees interested in a career in academic medicine and clinical investigation.

Lesley Curtis, PhD Interim Director

Contact Information

Office : DCRI, North Pavilion, 2400 Pratt Street, Durham, NC 27705 Campus mail : DUMC Box 3850, Durham, NC 27710 Phone : 919-668-8749 Fax : 919-668-7103

For more information:  dcri.duke.edu

Duke Clinical Research Institute's 25 Years of Vision

From the moment that Adrian Hernandez, MD, MHS , professor of medicine in cardiology, stepped to the helm of the Duke Clinical Research Institute (DCRI) in May 2020, he faced the prospect of steering the organization through uncharted and fast-changing waters.

The world was in the early throes of the COVID-19 pandemic. The DCRI, the world’s largest academic clinical research organization, houses eight primary therapeutic areas, from musculoskeletal to neuroscience, under one roof. Now it was all hands on deck to face COVID. Experts in infectious disease, critical care, pediatrics, and cardiology alike pivoted to focus on pandemic-related research in addition to their primary research programs. Faculty and staff worked day and night to organize and launch new research programs aimed at answering urgent questions, such as understanding how frontline health care workers were affected by the pandemic and investigating whether approved drugs could be repurposed to treat COVID-19 symptoms at home. The DCRI soon became Duke University’s largest recipient of federal research dollars for COVID-19.

Things were changing not only within the DCRI, but across the entire clinical research ecosystem. Telehealth or virtual visits became commonplace, and it soon became clear that more research could be conducted remotely outside the clinic by leveraging digital health technologies and meeting patients in their communities. Faced with the need to rapidly develop COVID-19 vaccines, scientific processes that would normally take years were accelerated and completed successfully in a fraction of that time. 

In response to the changing research world, Hernandez, who is also a vice dean for the Duke University School of Medicine, began to identify top priorities for the DCRI, among them a robust digital strategy and decentralized trials, which essentially take clinical trials to the subjects rather than gathering subjects together at a central site. 

But as Hernandez charted the path for DCRI’s future and responded to so much change, he was also struck by what had held fast: the institute’s mission to develop, share, and implement knowledge that improves health around the world through innovative clinical research.

“DCRI’s employees are profoundly mission-oriented,” said Hernandez. “Everyone quickly leaned in to developing creative and trustworthy methods for addressing the most pressing questions of the pandemic.”

An Enduring Vision  

Upon becoming executive director, Hernandez gently finessed the mission statement, changing “improving patient care around the world” to “improving health around the world” to reflect DCRI’s expertise in preventive care and health for all. 

Overall, however, the thrust of the DCRI’s mission remains unchanged from what it was 25 years ago when the institute was founded by Robert Califf, MD (currently nominated for a second stint as commissioner of the U.S. Food and Drug Administration).

During this 25 th anniversary year, the DCRI has reflected on its first quarter-century — and on where the next quarter-century will take it. When current and former faculty and staff — including Hernandez and the other four individuals who have had a turn as executive director — talk about the institute, the theme that arises again and again is the DCRI’s enduring vision, which underpins its mission and activities.

“The Duke Clinical Research Institute, which was formally created 25 years ago, began with a vision: to usher in a different approach to learn about health and illness, and to apply these learnings to improve health care,” said Califf, who led the institute from its inception in 1996 until 2006.

Over the past 25 years, that vision has coalesced into five broad categories of endeavor:

Generating World-Class Evidence to Improve Health  

Central to DCRI’s vision and mission is the process of evidence generation through clinical trials and observational studies. Cardiologist Robert Harrington, MD, who was the DCRI’s executive director between 2006 and 2012 and is now Arthur L. Bloomfield professor of medicine and chairman of the department of medicine at Stanford University, said collaboration was key.

Harrington said the DCRI always fostered a strong collaborative spirit both internally and externally. Projects succeeded because a unique bond formed among clinicians, statisticians, and operational experts who were able to work together seamlessly to deliver on research efforts. The DCRI was also successful in collaborating with academic partners and pharma companies outside its walls to complete successful studies and help advance development of new treatments.

The culture of mutual support and collaboration is deeply embedded in the DCRI, and Harrington expects it to continue to yield benefits even as technology and science evolve rapidly.

“There are a lot of questions in clinical medicine that we don’t know the answer to,” Harrington said. “And I’m confident that the next version of DCRI will focus on how we collect data and turn it into evidence and informed clinical practice going forward.”

Sharing and Implementing Knowledge Widely  

As an academic institution, the DCRI regards peer-reviewed publication as an essential part of the research process because it enables researchers to share scientific findings with their peers across academia and industry. 

Since DCRI’s inception in 1996, the institute has disseminated over 17,500 publications , and findings from the DCRI have been cited in over 760,000 scientific articles. Several researchers with ties to the DCRI are named year after year to a global “highly cited researchers” list , including cardiologist Eric Peterson, MD, MPH, who directed the institute from 2012 to 2018 and is now vice provost and senior associate dean for clinical research as well as vice president for health system research at UT Southwestern Medical Center.

DCRI’s commitment to sharing knowledge extends far beyond just academic publications. In recent years, the institute has become a leader in developing research summaries for lay audiences and implementing other strategies to share study results with people who participated in the studies.

The DCRI is also heavily focused on implementation science: determining the most effective ways to implement evidence-based therapies and treatment strategies into clinical practice. This focus is narrowing the gap between research projects and treatment protocols — a much-needed change in an environment in which it takes an average of 17 years for clinical trials results to be adopted into patient care.

“Researchers do research for many reasons, and many are driven by knowing the answer,” Peterson said. “But at the DCRI, it’s not just about that; it’s about helping patients. While we certainly do research for the academic and intellectual reasons, the main reason is to impact the world and learn about how we treat patients, and ultimately, how we can care for them better. To get to that spot, we need to disseminate the findings of our work.”

Creating Novel Methods that Accelerate Clinical Research  

The DCRI could not generate evidence successfully without continuously developing novel methods to answer increasingly difficult questions and make research more efficient. From the explosion of big data to the rapid emergence and spread of a never-before-seen disease, recent events have underscored the need for great minds to work on new ways to solve problems.

The DCRI has employed novel approaches in many of its research projects, such as successfully conducting the demonstration project showing how to leverage the National Patient-Centered Clinical Research Network (PCORnet), or leading the way in newer, more flexible trial designs. Duke population health scientist Lesley Curtis, PhD , who led the institute as its interim executive director from 2018 to 2020, said that DCRI’s ability to create novel methods has helped the institute address urgent needs.

“DCRI creates new ways of doing things not just for the sake of creating new methods and new ways of doing things, but to solve specific problems,” she said. “And those problems are often barriers that prevent us from — or maybe impede us from — generating the kind of evidence that patients and clinicians need. It’s really imperative for us to keep our creative thinking caps on.”

Improving Health Equity through Our Research  

As Hernandez looks to the future of the DCRI, he sees improving health equity as one of its most important goals. While the DCRI has long endeavored to improve health for all, Hernandez and other institute leadership know that greater steps must be taken to reach this goal.

Study teams, for example, must work to enroll more diverse study populations so that results from clinical trials can be accurately applied to all populations. There are many root causes for the current lack of diversity in the clinical trial environment, one of which is a lack of diversity in clinical trials leadership.

Hernandez has committed to addressing these and other related issues through instating a Diversity, Equity, and Inclusion (DEI) office within the DCRI. Longtime Duke and DCRI employee Linda Davidson-Ray, MA, was selected to lead this office. She is tasked with strengthening DEI efforts within the DCRI, collaborating with the Duke School of Medicine’s Office of Diversity and Inclusion , and developing a platform for health equity research that can be shared and built upon with external partners.

“Especially the last five years, we’ve seen these health inequities worsen in different areas of the country,” Hernandez said. “We have this national footprint where we can close the gap. We have the resolve to bring the best minds together, not only at DCRI or Duke, but with other partners as well across academia, industry, and government agencies. We’re directly trying to address this by bringing those stakeholders together to design the solutions, test them out, and then show what works and also what doesn’t work.”

Developing the Next Generation of Clinical Researchers  

Perhaps the most critical part of DCRI’s vision, which will serve to advance both the institute and the clinical research field for the next 25 years, is its commitment to developing the next generation of clinical researchers.

Harrington began his research career as a fellow at the Duke Databank for Cardiovascular Disease, which laid the groundwork for the founding of the DCRI. Since then, under the leadership of Harrington and others, the DCRI Fellowship Program has been formalized and expanded, equipping over 300 trainees with the skills needed to lead the clinical trials of tomorrow. It includes trainees with a diverse range of expertise, from musculoskeletal research to nephrology to cardiology, and attracts trainees from across the globe, from Canada to Australia: thus far the program has trained 64 fellows from 22 non-U.S. countries.

But even before there was a formal fellowship program, training and mentoring were important values of the institute, ingrained into its mission from its earliest days.

“From the beginning, the forte of the DCRI was putting trainees into the mix of getting trials and outcomes studies done — working with the study coordinators and the data experts and the statisticians to learn how it's done,” Califf said.

And the consensus among directors past and present? That early mission still rings true today, and is delivered through DCRI’s vision.

“T he mission is as relevant today — even with some tweaks to the wording — as it was when we first put it into play 25 years ago,” Harrington said. “My advice to future DCRI directors: Stay focused on the mission.”

Kaitl in Jansen is a former senior communications specialist at the Duke Clinical Research Institute.  

DCRI Celebrates 25 Years

The DCRI was founded in 1996, following in the footsteps of Duke pioneers who envisioned novel ways to learn about health and health care. Twenty-five years later, that spirit of innovation has enabled the DCRI to affect change in most every aspect of clinical research and realize its mission to improve health around the world.

Responding Rapidly to a Pandemic

As the COVID-19 pandemic quickly became the most pressing health issue around the globe, the DCRI worked to rapidly create research programs to learn more about the novel disease. The DCRI’s work in this area has been supported by a number of funders, from the Patient-Centered Outcomes Research Institute (PCORI) to the National Institutes of Health (NIH) to Pfizer.

Federally-Supported Programs

Advancing New Treatments

The DCRI plays an essential role in two master protocols that are part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) program, which is administered by the NIH. The DCRI serves as:

• The U.S. coordinating center for ACTIV-1, which studies multiple immune modulators that may prevent the overactive immune response that occurs in some severe COVID-19 cases.
• The coordinating center for ACTIV-6, a platform trial designed to understand whether already-approved drugs for other indications could be effective in treating COVID-19 at home.

Expanding Access to Testing

The DCRI is partnering with the UNC Center for Health Equity Research and Community-Campus Partnerships for Health to co-lead Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP). The program, which aims to expand access to COVID-19 testing, is supported by the NIH.

LEARN MORE ABOUT RADX-UP

Studying Community Transmission

RADx-UP also supports Say Yes! COVID Test, a program that is testing whether making self-administered COVID-19 tests available in specific communities helps to reduce community transmission. Say Yes! COVID Test is supported by the NIH.

LEARN MORE ABOUT SAY YES! COVID TEST

Distributing Free Tests in Underserved Communities

You & Me COVID-Free provided free COVID-19 tests in underserved communities and is evaluating whether they are an effective way to reduce community transmission when used prior to gathering with others.

LEARN MORE ABOUT YOU & ME COVID-FREE

REDUCING TRANSMISSION IN SCHOOLS

DCRI pediatricians lead the ABC Science Collaborative, which found that last fall, school districts that required masking within schools saw lower rates of COVID-19 transmission compared to those with optional masking policies.

STUDYING VACCINE SAFETY

The DCRI and Verily Life Sciences are partnering to lead HERO-TOGETHER, a study funded by Pfizer that will follow vaccinated healthcare worker for two years to better understand their experiences after receiving COVID-19 vaccines.

GENERATING EVIDENCE ACROSS THE GLOBE

DCRI’s Renato Lopes, MD, PhD, worked with colleagues in Brazil to conduct a series of trials tackling different questions related to COVID-19, such as whether it is safe to continue ACEI/ARB therapy in patients with COVID-19.

SEE THE RESULTS

Making Rapid Research a Reality

Like the rest of the world, the DCRI was forced to respond rapidly to the COVID-19 pandemic, launching its first program, a nationwide community of healthcare workers, in a few short weeks. In the video above, watch as DCRI Executive Director Adrian Hernandez, MD, MHS, speaks with DCRI Program Manager Lauren Cohen, MA, about how this project came to fruition so quickly—and which aspects of rapid start-up can be applied to other pressing public health issues.

Sharing Our Expertise

DCRI researchers are not only leading the way forward in developing knowledge about the COVID-19 pandemic; they’re also sharing that knowledge with the public by speaking with the media.

• A study conducted by the ABC Science Collaborative, a group working on a  data-driven approach to safely reopen schools , was cited in many national outlets, including  The Washington Post ,  Forbes , and  The Atlantic .
• DCRI Executive Director Adrian Hernandez, MD, MHS, spoke with  The Washington Post  about  clinical trials infrastructure during COVID-19 . He also authored a  STAT First Opinion  piece about the COVID-19 vaccine trials.
• DCRI cardiologist John Alexander, MD, MHS, weighed in on  how COVID-19 will impact future clinical trials  in a conversation with  Scientific American .

Collaborating to Fight COVID-19

DCRI researchers have teamed up with colleagues across the University to conduct impactful projects during the COVID-19 pandemic.

• DCRI’s Manesh Patel, MD, partners with the Duke Institute for Health Innovation as a leader of the Pandemic Response Network, a resource that allows people to sign up for help tracking and managing their symptoms.
• DCRI’s Jessilyn Dunn, PhD, is one of the lead investigators for  CovIdentify , a study conducted by Duke’s Pratt School of Engineering to determine whether smartphones and wearables can aid in early detection of COVID-19.
• DCRI’s Scott Palmer, MD, MHS, teamed up with colleagues across Duke University School of Medicine to conduct research to better understand  why some people have more severe cases of COVID-19   than others.

Recent DCRI COVID-19 Research News

COVID-19 Testing Programs Share How to Engage Diverse Communities in Public Health

Out of the Hospital, Not Out of the Woods

DCRI selected as Clinical Trials Data Coordinating Center for NIH RECOVER Long COVID Initiative

COVID Vaccination Not Associated with Kidney Disease in Black Adults at High Risk

Using data from community studies based at  Duke Kannapolis , researchers found that COVID vaccination was not associated with new onset of APOL1-related kidney disease in African American adults who were at high risk for the condition.

The findings were published June 20 by  Kidney International Reports . The authors concluded that validation of their result in larger cohorts would further support the renal safety of COVID vaccine in people with APOL1 high-risk genotype. Duke Kannapolis — CTSI's research site at the North Carolina Research Campus — is part of the new Center for Precision Health . The COVID vaccination research used data from the MURDOCK Study , led by Svati H. Shah, MD, MHS, and the  Duke APOL1 Study , led by Opeyemi A. Olabisi, MD. Shah directs Duke Kannapolis and the Center for Precision Health and is principal investigator for the MURDOCK Study.

• Current Employees
• Duke & Durham
• Human Resources
• Connect With Us
• External Applicants
• Current Duke Employees
• Duke Health Careers

Clinical Research Coordinator

Durham, NC, US, 27710

School of Medicine

Established in 1930, Duke University School of Medicine is the youngest of the nation's top medical schools. Ranked sixth among medical schools in the nation, the School takes pride in being an inclusive community of outstanding learners, investigators, clinicians, and staff where interdisciplinary collaboration is embraced and great ideas accelerate translation of fundamental scientific discoveries to improve human health locally and around the globe. Composed of more than 2,600 faculty physicians and researchers, nearly 2,000 students, and more than 6,200 staff, the Duke University School of Medicine along with the Duke University School of Nursing, and Duke University Health System comprise Duke Health, a world-class academic medical center. The Health System encompasses Duke University Hospital, Duke Regional Hospital, Duke Raleigh Hospital, Duke Health Integrated Practice, Duke Primary Care, Duke Home Care and Hospice, Duke Health and Wellness, and multiple affiliations.

Occupational Summary

Provide leadership and coordination in the conduct of multiple, complex oncology clinical trials and research studies including Investigational Products [IP] for the Duke Cancer Institute’s [DCI] M ultis i te T rials Serv i ce C enter (MiSTiC) in the Oncology Clinical Research Unit, which oversees the conduct of DCI clinical research.

Work Preformed

Operations, Study and Site Management – 60% Effort

• Employ strategies to maintain recruitment and retention rates across all participating sites and assist with individual site needs as appropriate. Collect information from external sites to determine appropriate study feasibility, recruitment, and retention strategies. Evaluate processes to identify issues related to recruitment and retention rates at all participating sites; offer solutions as appropriate.
• Serves as an expert resource to multiple study teams/research program regarding regulatory and institutional policies and processes. Prepares for and provides support for study monitoring and audit visits, including support for the reviewer. Addresses and corrects findings.
• Develops consent plans and documents for participants in a variety of studies. Develops and submits documentation and information for IRB review. Communicates with the IRB staff and reviewers and handles issues appropriately. Prepares and submits documents needed for regulatory and safety reporting to sponsors and other agencies.
• Coordinate study activities with teammates and colleagues to successfully steer the Duke study start up processes, navigate regulatory approvals, activate participating sites, manage and monitor the conduct of multisite studies. Recognize and offer solutions to study problems. Escalate issues appropriately. Take part in site initiation and closeout visits. Assist in the development of new studies.
• Work closely with the Principal Investigator [PI] and study team to monitor recruitment, screening and enrollment of participants across all participating sites. Collect documentation of informed consent process, eligibility verification and enrollment and study visits of participants as appropriate. Track biospecimen collection, processing, storage and shipping across labs and maintain the master specimen log.
• Initiate, manage and maintain the Duke regulatory application for multisite studies; monitor and manage regulatory documentation from external sites. Maintain study's compliance with institutional requirements and policies. Oversee continuing renewals and amendments approvals. Maintain appropriate study-level documentation including regulatory binders, enrollment logs, and patient registration in the system of record. Oversee maintenance of Delegation of Authority Logs and training of key personnel on study specific duties. Track and maintain Deviation Logs across all participating sites.
• Assist with the development of Conflict of Interest [COI], Data Safety Monitoring Plans [DSMPs], and Duke Research Data Lifecycle (DRDLs) as appropriate. Assist with the coordination of monitoring visits for all participating sites.
• Follow procedures and documentation to aid in the payment of external site invoices. Monitor financial study milestones and report appropriately. Coordinate with financial teams and participate in budget development for multisite studies. Assist with study budgets and closeouts.

Communication – 15% Effort

• Serve as liaison with participating sites, study personnel and PI for multisite studies.
• Collaborate, and communicate with other study personnel as required.
• Communicate concerns clearly in a professional manner.
• Respond timely to emails, phone calls and questions.
• Refer more complex questions and escalate issues to others as appropriate.
• Uses advanced subject matter expertise in the therapeutic area or clinical research to solve problems. Communicates effectively with others, regardless of reporting relationship, to accomplish shared work objectives.

Data – 10% Effort

• Use Electronic Data Capture [EDC] systems to oversee and manage data collection. Detect issues related to data capture, collection or management and suggest solutions.
• Comply with required processes, policies, and systems to ensure data security and provenance. Recognize and report vulnerabilities related to security of physical and electronic data. Assist in investigating incomplete, inaccurate, or missing data and documents to ensure accuracy and completeness of data.

Leadership –5% Effort

• Actively network. Provide leadership within the team. Actively and proactively participate in team meetings, committees, task forces and ad hoc groups.
• Encourage career development by actively seeking out continuing education opportunities. Participate in scientific presentations and publications.
• Serve as an expert resource for colleagues and teammates. Mentor staff, including those in the same job title. Support colleagues in their project work; encourage completion.
• Serves on committees and workgroups internal to Duke or externally in therapeutic area of research. Demonstrates interpersonal skills to get work done efficiently. Recognizes and escalates organizational issues that could be optimized to improve research process. Demonstrates resilience and is adaptive to change.

Ethics – 10% Effort

• Know and follow policies, standard operating procedures [SOPs], regulations and protocol requirements that govern clinical research. Maintain Duke and project specific training and certification requirements.
• Communicate to study staff the difference between clinical and research activities, and the risks and benefits of study participations. Recognize when staff are having difficulty with the distinction and work hard to help them understand the differences.
• Summarize and clarify for study teams the professional guidelines and code of ethics related to the conduct of clinical research.

Other work as assigned.

The intent of this job description is to provide a representative and level of the types of duties and responsibilities that will be required of positions given this title and shall not be construed as a declaration of the total of the specific duties and responsibilities of any particular position. Employees may be directed to perform job-related tasks other than those specifically presented in this description.

Minimum Qualifications

Completion of an Associate's degree

Work requires a minimum of two years of relevant research experience. A Bachelor's degree may substitute for 2 years required experience.

Preferences

• The preferred candidate will have oncology or research experience, training, education, or clinical trials coordination experience.
• Regulatory experience preferred but not required including regulatory management skills for example IRB approvals, knowledge of iRIS, and Oncore and knowledge of institutional SOPs at the least.
• Multisite regulatory experience preferred but not required.

Job Code: 00001201 CLINICAL RESEARCH COORDINATOR Job Level: 52

Duke is an Affirmative Action/Equal Opportunity Employer committed to providing employment opportunity without regard to an individual's age, color, disability, gender, gender expression, gender identity, genetic information, national origin, race, religion, sex, sexual orientation, or veteran status.

Duke aspires to create a community built on collaboration, innovation, creativity, and belonging. Our collective success depends on the robust exchange of ideas—an exchange that is best when the rich diversity of our perspectives, backgrounds, and experiences flourishes. To achieve this exchange, it is essential that all members of the community feel secure and welcome, that the contributions of all individuals are respected, and that all voices are heard. All members of our community have a responsibility to uphold these values.

Essential Physical Job Functions: Certain jobsat Duke University and Duke University Health System may include essential job functions that require specific physical and/or mental abilities. Additional information and provision for requests for reasonable accommodation will be provided by each hiring department.

Nearest Major Market: Durham Nearest Secondary Market: Raleigh

Duke is an Affirmative Action / Equal Opportunity Employer committed to providing employment opportunity without regard to an individual’s age, color, disability, gender, gender expression, gender identity, genetic information, national origin, race, religion, sex, sexual orientation, or veteran status. Read more about Duke’s commitment to affirmative action and nondiscrimination at hr.duke.edu/eeo.

Welcome to the Duke Cancer Institute, one of the premier cancer centers in the U.S.

Together, we can re-imagine how to defeat cancer. Learn about the many ways you can partner with us.

DCI offers access to groundbreaking clinical trials and treatments unmatched by other centers.

Appointments available within 48 hours. Call the Oncology Access Center and schedule an appointment today.

Learn about patient care, treatment advances and clinic locations on DukeHealth.org.

News from DCI

Read about important research breakthroughs, clinical innovations, and significant achievements made by DCI members, faculty, and staff.

Beyond Cancer: Confronting the Challenges of Survivorship

In a new Medscape series called "Beyond Cancer: Confronting the Challenges of Survivorship," DCI physicians and patients discuss how an innovative approach of providing onco-primary care, along with collaborative research efforts, has informed improvements in screening, treatment, and post-treatment care.

Patient’s Gift Launches Melanoma Survivorship Program

Quit at Duke

DCI Centers of Excellence

DCI Centers of Excellence bring together multidisciplinary teams of nationally recognized specialists to move the needle in cancer research and treatment. Members of these unique, innovative Centers represent basic science, clinical research, patient care, and education. Our mission is to discover new approaches to research and treatment care that push the boundaries of what we know now.

Education and Training

Research and education, training opportunities.

Cancer Research at DCI

Community Outreach, Engagement and Equity

Our mission is to reduce the burden of cancer and promote health equity in the Duke Cancer Institute catchment area and beyond.

News and Events

How Cancer Tumors Hijack the Body’s Defense System

Duke Cancer Review

Strike Out For Sarcoma 5K & 10K Run/Walk

Tee Off vs Cancer

to the Duke Cancer Institute

With your help, we can re-imagine how to defeat cancer. Explore the many ways you can partner with us.

at the Duke Cancer Institute

Be part of a team whose goal is to discover, develop, and deliver the future of cancer care now.

Advertise with us

• Search for candidates
• Recruiting Physicians Today

Employer sign in

For Employers

• Skip to main menu
• Skip to user menu

Duke General Pediatrics/Duke Clinical Research Institute Faculty Position

Share this job

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Before you apply - Turn on alerts for jobs like this!

We'll send them straight to your inbox :

When you create this job alert we will email you a selection of jobs matching your criteria. Our terms and conditions and privacy policy apply to this service and all emails will contain a link in the footer to enable you to unsubscribe at any time.

By clicking to continue to apply below, your email address will be shared with the employer.

Trying to Reach Decision Makers?

1-20 of 105 Contacts

Test Drive ZoomInfo's Directories